Publications
Found 171 results
Filters: Author is Muyldermans, Serge [Clear All Filters]
"Nanobody-coupled microbubbles as novel molecular tracer.",
J Control Release, vol. 158, issue 2, pp. 346-53, 2012 Mar 10.
"Pre-clinical studies of toxin-specific nanobodies: evidence of in vivo efficacy to prevent fatal disturbances provoked by scorpion envenoming.",
Toxicol Appl Pharmacol, vol. 264, issue 2, pp. 222-31, 2012 Oct 15.
"Using microdialysis to analyse the passage of monovalent nanobodies through the blood-brain barrier.",
Br J Pharmacol, vol. 165, issue 7, pp. 2341-53, 2012 Apr.
"A case of convergence: why did a simple alternative to canonical antibodies arise in sharks and camels?",
PLoS Biol, vol. 9, issue 8, pp. e1001120, 2011 Aug.
"Correlation between epidermal growth factor receptor-specific nanobody uptake and tumor burden: a tool for noninvasive monitoring of tumor response to therapy.",
Mol Imaging Biol, vol. 13, issue 5, pp. 940-8, 2011 Oct.
"Development of Cys38 knock-out and humanized version of NbAahII10 nanobody with improved neutralization of AahII scorpion toxin.",
Protein Eng Des Sel, vol. 24, issue 9, pp. 727-35, 2011 Sep.
"Evaluation of a nanobody phage display library constructed from a Brucella-immunised camel.",
Vet Immunol Immunopathol, vol. 142, issue 1-2, pp. 49-56, 2011 Jul 15.
"Generation of anti-infectome/anti-proteome nanobodies.",
Methods Mol Biol, vol. 790, pp. 239-59, 2011.
"High affinity nanobodies against the Trypanosome brucei VSG are potent trypanolytic agents that block endocytosis.",
PLoS Pathog, vol. 7, issue 6, pp. e1002072, 2011 Jun.
"Immunological aspects of scorpion toxins: current status and perspectives.",
Inflamm Allergy Drug Targets, vol. 10, issue 5, pp. 358-68, 2011 Oct.
"Localization, mechanism and reduction of renal retention of technetium-99m labeled epidermal growth factor receptor-specific nanobody in mice.",
Contrast Media Mol Imaging, vol. 6, issue 2, pp. 85-92, 2011 Mar-Apr.
"Preclinical screening of anti-HER2 nanobodies for molecular imaging of breast cancer.",
FASEB J, vol. 25, issue 7, pp. 2433-46, 2011 Jul.
"Recent developments in engineering and delivery of protein and antibody therapeutics.",
Curr Opin Biotechnol, vol. 22, issue 6, pp. 839-42, 2011 Dec.
"A simple quantitative affinity capturing assay of poliovirus antigens and subviral particles by single-domain antibodies using magnetic beads.",
J Virol Methods, vol. 173, issue 2, pp. 300-5, 2011 May.
"Specific cell targeting with nanobody conjugated branched gold nanoparticles for photothermal therapy.",
ACS Nano, vol. 5, issue 6, pp. 4319-28, 2011 Jun 28.
"TAFIa inhibiting nanobodies as profibrinolytic tools and discovery of a new TAFIa conformation.",
J Thromb Haemost, vol. 9, issue 11, pp. 2268-77, 2011 Nov.
"A bispecific nanobody to provide full protection against lethal scorpion envenoming.",
FASEB J, vol. 24, issue 9, pp. 3479-89, 2010 Sep.
"Direct injection of functional single-domain antibodies from E. coli into human cells.",
PLoS One, vol. 5, issue 12, pp. e15227, 2010.
"Generation and characterization of inhibitory nanobodies towards thrombin activatable fibrinolysis inhibitor.",
J Thromb Haemost, vol. 8, issue 6, pp. 1302-12, 2010 Jun.
"In vitro analysis and in vivo tumor targeting of a humanized, grafted nanobody in mice using pinhole SPECT/micro-CT.",
J Nucl Med, vol. 51, issue 7, pp. 1099-106, 2010 Jul.
"In vitro antiviral activity of single domain antibody fragments against poliovirus.",
Antiviral Res, vol. 87, issue 2, pp. 257-64, 2010 Aug.
"Minimum information about a protein affinity reagent (MIAPAR).",
Nat Biotechnol, vol. 28, issue 7, pp. 650-3, 2010 Jul.
"Modulation of protein properties in living cells using nanobodies.",
Nat Struct Mol Biol, vol. 17, issue 1, pp. 133-8, 2010 Jan.
"Nanobodies as tools for in vivo imaging of specific immune cell types.",
J Nucl Med, vol. 51, issue 5, pp. 782-9, 2010 May.
"Nanobodies®: proficient tools in diagnostics.",
Expert Rev Mol Diagn, vol. 10, issue 6, pp. 777-85, 2010 Sep.